American Medical Systems Holdings, Inc. and Caldera Medical, Inc. today announced that they have entered into a settlement and cross-license agreement. AMS filed suit against Caldera in November 2005 claiming that Caldera infringed on certain patents related to treating stress urinary incontinence. The companies have entered into a restricted, royalty bearing cross-license agreement that covers a broad intellectual property portfolio of both incontinence and prolapse technologies, allowing each company to focus upon providing solutions to patients. The cross-license restriction relates to the ability for the companies to protect the uniqueness of their products. AMS has subsequently dismissed the suit.
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Biom’up’s Laparoscopic Applicator Earns New Marketing Approval
The device quickly delivers Hemoblast powder to bleeding areas in minimally-invasive surgeries.
Lawmakers Want Probe of BMS/Celgene Deal
The cancer drugs the company will acquire as part of the deal include Celgene’s blockbuster drug Revlimid.
